X-ray equipment manufacturer Del Global Technologies has obtained final approval from the Securities and Exchange Commission regarding the settlement of claims against the company in connection with the restatement of financial statements filed by former
X-ray equipment manufacturer Del Global Technologies has obtained final approval from the Securities and Exchange Commission regarding the settlement of claims against the company in connection with the restatement of financial statements filed by former management for the fiscal years 1997 through the third quarter of fiscal 2000. The terms of the settlement are subject to approval by the U.S. District Court for the Southern District of New York. Del Global signed a consent decree with the SEC in December involving payment of a civil penalty of $400,000. The company is primarily engaged in the design, manufacture, and marketing of x-ray systems for the medical and dental markets, as well as high-voltage power conversion subsystems for medical and other industrial applications.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.